Callan Family Office’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.5M | Buy |
16,033
+4,146
| +35% | +$1.68M | 0.21% | 116 |
|
|
2025
Q1 | $5.91M | Sell |
11,887
-2,147
| -15% | -$1.07M | 0.44% | 50 |
|
|
2024
Q4 | $7.3M | Buy |
14,034
+9,012
| +179% | +$4.69M | 0.46% | 41 |
|
|
2024
Q3 | $3.11M | Buy |
5,022
+871
| +21% | +$539K | 0.52% | 37 |
|
|
2024
Q2 | $2.3M | Buy |
4,151
+2,864
| +223% | +$1.58M | 0.44% | 38 |
|
|
2024
Q1 | $748K | Buy |
1,287
+503
| +64% | +$292K | 0.18% | 50 |
|
|
2023
Q4 | $416K | Buy |
784
+97
| +14% | +$51.5K | 0.1% | 62 |
|
|
2023
Q3 | $348K | Sell |
687
-462
| -40% | -$234K | 0.09% | 65 |
|
|
2023
Q2 | $599K | Sell |
1,149
-1,138
| -50% | -$594K | 0.16% | 58 |
|
|
2023
Q1 | $1.32M | Buy |
2,287
+1,006
| +79% | +$580K | 0.32% | 47 |
|
|
2022
Q4 | $705K | Buy |
+1,281
| New | +$705K | 0.23% | 46 |
|